DARE (Dare Bioscience, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Dare Bioscience, Inc. Common Stock (DARE) is a publicly traded Healthcare sector company. As of May 21, 2026, DARE trades at $2.36 with a market cap of $31.61M and a P/E ratio of -2.46. DARE moved +5.11% today. Year to date, DARE is +17.09%; over the trailing twelve months it is -19.38%. Its 52-week range spans $1.27 to $9.19. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns DARE stock?
Hedge funds tracked by Rallies that own DARE include Two Sigma and Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Dare Bioscience, Inc. Common Stock.
DARE Key Metrics
Key financial metrics for DARE
Metric
Value
Price
$2.36
Market Cap
$31.61M
P/E Ratio
-2.46
EPS
$-0.96
Dividend Yield
0.00%
52-Week High
$9.19
52-Week Low
$1.27
Volume
338
Avg Volume
0
Revenue (TTM)
$1.16M
Net Income
$-12.02M
Gross Margin
0.00%
Top Hedge Funds Holding DARE
Two Sigma holds 102.90K shares of DARE, changed +209.07% as of Jun 30, 2024.
Renaissance Technologies holds 68.69K shares of DARE, changed +6.68% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own DARE include Two Sigma and Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Dare Bioscience, Inc. Common Stock.
Does Rallies show 13F holders for DARE?
Yes. Rallies tracks hedge fund and 13F ownership data for DARE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is DARE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DARE. It does not provide personalized investment advice.
